Literature DB >> 27469233

Breast cancer: FASN inhibitor increases survival.

Sarah Crunkhorn.   

Abstract

Entities:  

Year:  2016        PMID: 27469233     DOI: 10.1038/nrd.2016.148

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Fasnall, a Selective FASN Inhibitor, Shows Potent Anti-tumor Activity in the MMTV-Neu Model of HER2(+) Breast Cancer.

Authors:  Yazan Alwarawrah; Philip Hughes; David Loiselle; David A Carlson; David B Darr; Jamie L Jordan; Jessie Xiong; Lucas M Hunter; Laura G Dubois; J Will Thompson; Manjusha M Kulkarni; Annette N Ratcliff; Jesse J Kwiek; Timothy A J Haystead
Journal:  Cell Chem Biol       Date:  2016-06-02       Impact factor: 8.116

  1 in total
  1 in total

1.  Modulation of Breast Cancer Cell FASN Expression by Obesity-Related Systemic Factors.

Authors:  Bryan McClellan; Tommy Pham; Brittany Harlow; Gabby Lee; Duan Quach; Christopher Jolly; Andrew Brenner; Linda deGraffenried
Journal:  Breast Cancer (Auckl)       Date:  2022-08-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.